MX9201113A - Metodo para identificar o tamizar agonistas o antagonistas de la amilina. - Google Patents

Metodo para identificar o tamizar agonistas o antagonistas de la amilina.

Info

Publication number
MX9201113A
MX9201113A MX9201113A MX9201113A MX9201113A MX 9201113 A MX9201113 A MX 9201113A MX 9201113 A MX9201113 A MX 9201113A MX 9201113 A MX9201113 A MX 9201113A MX 9201113 A MX9201113 A MX 9201113A
Authority
MX
Mexico
Prior art keywords
amylin
antagonists
screening
identifying
agonists
Prior art date
Application number
MX9201113A
Other languages
English (en)
Inventor
Kevin Beaumont
Timothy J Rink
Original Assignee
Amylin Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amylin Corp filed Critical Amylin Corp
Publication of MX9201113A publication Critical patent/MX9201113A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
MX9201113A 1991-03-15 1992-03-13 Metodo para identificar o tamizar agonistas o antagonistas de la amilina. MX9201113A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/670,231 US5264372A (en) 1991-03-15 1991-03-15 Receptor-based screening methods for amylin agonists and antagonists

Publications (1)

Publication Number Publication Date
MX9201113A true MX9201113A (es) 1992-10-01

Family

ID=24689539

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9201113A MX9201113A (es) 1991-03-15 1992-03-13 Metodo para identificar o tamizar agonistas o antagonistas de la amilina.

Country Status (13)

Country Link
US (1) US5264372A (es)
EP (1) EP0529065B1 (es)
JP (1) JPH05508226A (es)
AT (1) ATE172540T1 (es)
AU (1) AU1663092A (es)
CA (1) CA2082929A1 (es)
DE (1) DE69227347T2 (es)
DK (1) DK0529065T3 (es)
IL (5) IL101233A (es)
MX (1) MX9201113A (es)
TW (1) TW324064B (es)
WO (1) WO1992016845A1 (es)
ZA (1) ZA921884B (es)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580953A (en) * 1991-08-14 1996-12-03 Amylin Pharmaceuticals, Inc. Amylin antagonist peptides and uses therefor
BR9305525A (pt) * 1992-05-15 1995-03-01 Amylin Pharmaceuticals Inc Teste de anticorpos para amilina
WO1994018571A1 (en) * 1993-02-12 1994-08-18 Amylin Pharmaceuticals, Inc. Mcf-7 binding site assays
AU6524794A (en) * 1993-03-24 1994-10-11 Amylin Pharmaceuticals, Inc. Cloned receptors and methods for screening
GB9317193D0 (en) * 1993-08-18 1993-10-06 Zeneca Ltd Method
ZA946881B (en) * 1993-09-07 1995-10-30 Amylin Pharmaceuticals Inc Methods for treating gastrointestinal motility
US7115728B1 (en) * 1995-01-30 2006-10-03 Ligand Pharmaceutical Incorporated Human peroxisome proliferator activated receptor γ
WO1996031526A1 (en) * 1995-04-06 1996-10-10 Amylin Pharmaceuticals, Inc. Anti-obesity agents
US5739106A (en) * 1995-06-07 1998-04-14 Rink; Timothy J. Appetite regulating compositions
US6143718A (en) 1995-06-07 2000-11-07 Amylin Pharmaceuticals, Inc. Treatment of Type II diabetes mellutis with amylin agonists
CA2262647C (en) 1996-08-08 2007-12-04 Amylin Pharmaceuticals, Inc. Methods for regulating gastrointestinal motility
US5677279A (en) * 1996-12-16 1997-10-14 Amylin Pharmaceuticals, Inc. Methods and compositions for treating pain with amylin or agonists thereof
ES2247676T3 (es) 1997-01-07 2006-03-01 Amylin Pharmaceuticals, Inc. Uso de las exendinas y de los agonistas de las mismas para la reduccion de la ingesta alimenticia.
US7101853B2 (en) 1997-05-06 2006-09-05 Amylin Pharmaceuticals, Inc. Method for treating or preventing gastritis using amylin or amylin agonists
US7910548B2 (en) 1997-06-06 2011-03-22 Amylin Pharmaceuticals, Inc. Methods for treating obesity
AU8588798A (en) 1997-07-25 1999-02-16 Institut Pasteur Human peroxisome proliferator activated receptor gamma (ppargamma) gene re gulatory sequences and uses therefor
US6936584B1 (en) 1998-02-13 2005-08-30 Amylin Pharmaceuticals, Inc. Mixed amylin activity compounds
EP1100888A2 (en) * 1998-05-26 2001-05-23 University Of Medicine And Dentistry Of New Jersey System for reproducing and modulating stability and turnover of rna molecules
US7399489B2 (en) * 1999-01-14 2008-07-15 Amylin Pharmaceuticals, Inc. Exendin analog formulations
ES2343072T3 (es) * 1999-01-14 2010-07-22 Amylin Pharmaceuticals, Inc. Exendina para la supresion del glucagon.
US20030087820A1 (en) * 1999-01-14 2003-05-08 Young Andrew A. Novel exendin agonist formulations and methods of administration thereof
US6924264B1 (en) * 1999-04-30 2005-08-02 Amylin Pharmaceuticals, Inc. Modified exendins and exendin agonists
AU775063C (en) 1999-04-30 2005-05-12 Amylin Pharmaceuticals, Inc. Modified exendins and exendin agonists
AU6219100A (en) * 1999-07-13 2001-05-14 Amylin Pharmaceuticals, Inc. The use of membranes, cells and tissue from the area postrema to identify therapeutic compounds
JP2004535151A (ja) * 2000-10-10 2004-11-25 インスティトゥート フューア ヴィロロギー タイルレヒツフェヒゲス インスティトゥート アン デア ヴェテリネーアメディツィニーシェン ウニヴェルズィテート ヴィーン ウイルス性成分の活性および／または特異性の評価に対する新システム
US20040005997A1 (en) * 2002-06-27 2004-01-08 The Procter & Gamble Company Methods for identifying compounds for regulating muscle mass of function using amylin receptors
MXPA05001264A (es) * 2002-08-06 2005-04-28 Aventis Pharma Gmbh Metodos para aislar una proteina intenstinal que se une al colesterol.
US8168233B2 (en) * 2002-10-18 2012-05-01 Amylin Pharmaceuticals, Inc. Treatment of pancreatitis with amylin
US20040214180A1 (en) * 2003-04-28 2004-10-28 Hironori Kobayashi Method and kit for determining quantity of protein
WO2005021026A2 (en) * 2003-08-29 2005-03-10 Amylin Pharmaceuticals, Inc. Methods for treating or ameliorating ghrelin-associated diseases and disorders
RU2385878C2 (ru) * 2004-02-11 2010-04-10 Амилин Фармасьютикалз, Инк. Пептид, обладающий свойствами амилина (варианты), и его применение (варианты)
US7399744B2 (en) * 2004-03-04 2008-07-15 Amylin Pharmaceuticals, Inc. Methods for affecting body composition
WO2006042242A2 (en) 2004-10-08 2006-04-20 Amylin Pharmaceuticals, Inc. Amylin family polypeptide- 6 (afp- 6) analogs and methods of making and using them
DE102004051014A1 (de) * 2004-10-20 2006-04-27 Rwth Aachen Chemisch modifizierte Peptidanaloga
US8394765B2 (en) * 2004-11-01 2013-03-12 Amylin Pharmaceuticals Llc Methods of treating obesity with two different anti-obesity agents
EP1814590B2 (en) 2004-11-01 2013-12-11 Amylin Pharmaceuticals, Inc. Treatment of obesity and related disorders
WO2006055167A1 (en) * 2004-11-12 2006-05-26 Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College Regulation of f1-atpase beta subunit cellular location
JP5114381B2 (ja) 2005-03-31 2013-01-09 アミリン・ファーマシューティカルズ，インコーポレイテッド 精神疾患および障害治療用アミリンおよびアミリンアゴニスト
EP1912666A2 (en) * 2005-07-22 2008-04-23 Amylin Pharmaceuticals, Inc. Use of amylin and amylin agonists as cardioprotective or myoprotective agents
BRPI0722276A2 (pt) * 2007-11-14 2014-04-22 Amylin Pharmaceuticals Inc Métodos para tratar obesidade e doenças e distúrbios relacionados à obesidade
EP2504019A2 (en) 2009-11-25 2012-10-03 ArisGen SA Mucosal delivery composition comprising a peptide complexed with a crown compound and/or a counter ion
WO2015004632A1 (en) * 2013-07-12 2015-01-15 Neotope Biosciences Limited Antibodies that recognize iapp

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4434236A (en) * 1982-10-20 1984-02-28 E. I. Du Pont De Nemours & Co. Immunoassay wherein labeled antibody is displaced from immobilized analyte-analogue
AU631112B2 (en) * 1988-01-11 1992-11-19 Amylin Corporation Treatment of type 2 diabetes mellitus
AU620727B2 (en) * 1989-07-10 1992-02-20 Amylin Pharmaceuticals, Inc. Treatment of obesity and essential hypertension and related disorders

Also Published As

Publication number Publication date
EP0529065A1 (en) 1993-03-03
IL120081A0 (en) 1997-04-15
EP0529065A4 (en) 1993-10-20
CA2082929A1 (en) 1992-09-16
ZA921884B (en) 1993-08-03
IL101233A0 (en) 1992-11-15
AU1663092A (en) 1992-10-21
DE69227347T2 (de) 1999-03-18
DK0529065T3 (da) 1999-06-28
IL101233A (en) 1997-04-15
TW324064B (en) 1998-01-01
EP0529065B1 (en) 1998-10-21
IL120082A (en) 1998-12-27
IL120082A0 (en) 1997-04-15
IL120081A (en) 1998-12-27
WO1992016845A1 (en) 1992-10-01
DE69227347D1 (de) 1998-11-26
ATE172540T1 (de) 1998-11-15
JPH05508226A (ja) 1993-11-18
US5264372A (en) 1993-11-23

Similar Documents

Publication Publication Date Title
MX9201113A (es) Metodo para identificar o tamizar agonistas o antagonistas de la amilina.
DK0593618T3 (da) Screeningsassay til påvisning af DNA-bindende molekyler
ATE408422T1 (de) Methode zur hemmung immunstimulatorischer mit dna assoziierter antworten
DE69232682D1 (de) Verfahren zur selektiven vermehrung von cd34 positiven zellen
DE155247T1 (de) Verfahren zur mikrophotometrie von mikroskopischen prueflingen, apparat zur ausfuehrung dieses verfahrens.
ES554795A0 (es) Un metodo de ensayo mejorado para la determinacion de analitos bioligicos tales como haptenos, antigenos ,receptores , farmacos y similares.
WO1999024463A3 (en) Signal peptide-containing proteins
DE69000128T2 (de) Vorrichtung zur spannungspruefung von proben aus gestein oder anderen materialien.
BR9406616A (pt) Método para triagem de agonistas receptores
BR9802456B1 (pt) aparelho, e, processo para obtenção de parafinas ou frações de parafinas.
ZA912303B (en) Protein partner screening assays and uses thereof
ES542864A0 (es) Aparato para la criofijacion de especimenes.
WO1998055509A3 (en) Two human dnaj-like proteins
ES2139225T3 (es) Metodo para escrutar bancos de compuestos.
ES522186A0 (es) Metodo de ensayo de anticuerpos.
ES2134810T3 (es) Diferenciacion de htlv-i y htlv-ii con la ayuda de peptidos sinteticos.
WO2000018915A3 (en) Membrane-associated organizational proteins
ATE301833T1 (de) Verfahren zum screenen einer die oligomerisierung von rezeptorproteinmolekülen fördernden substanz
WO2000011171A3 (en) Human rna-associated proteins
TH18474A (th) ลำดับดีเอนเอที่มีรหัสสำหรับหน่วยรับ bmp
WO1999019482A3 (en) Vesicle transport associated proteins
ES1042085Y (es) Equipo de elementos de analisis para la prueba de embarazo.